||Price in USD
|1|| Jun, 2020||Humira Drug Sales & Forecast|
Humira (adalimumab) is a biologic therapy administered as a subcutaneous injection. It is approved to treat the following autoimmune diseases such as rheu....
|2|| Jun, 2020||Toujeo Drug Sales & Forecast|
Toujeo is a solution for injection that contains the active substance insulin glargine. It is long-acting human insulin analogue indicated to improve glyc....
|3|| May, 2020||Lantus Drug Sales & Forecast|
Sanofi drug Lantus is a long-acting analog of human insulin, indicated for once-daily administration for the treatment of diabetes mellitus in adults, ado....
|4|| Apr, 2020||Trulicity Drug Sales & Forecast|
Eli Lilly drug Trulicity, for the treatment of type 2 diabetes is approved in the United States and Europe in 2014 and Japan in 2015. MNG Tracker report t....
|5|| Apr, 2020||Humalog Drug Sales & Forecast|
Eli Lilly drug Humalog Mix75/25 and Humalog Mix50/50 are used to treat adults with diabetes for the control of high blood sugar. Its patent has expired in....
|6|| Apr, 2020||Basaglar Drug Sales & Forecast|
Eli Lilly drug Basaglar (insulin glargine injection), a long-acting human insulin analog for the treatment of diabetes launched in the United Sates in 201....